Skip to main content
. 2013 Dec;103(12):e46–e53. doi: 10.2105/AJPH.2013.301328

TABLE 1—

Characteristics and Treatment of 3259 HIV-Infected Pregnant Women Enrolled in Medicaid: 14 Southern States, 2005–2007

Variable White, No. (%) or Mean ±SD Black, No. (%) or Mean ±SD Hispanics, No. (%) or Mean ±SD Other, No. (%) or Mean ±SD P
Total 457 (14.0) 2367 (72.6) 346 (10.6) 89 (2.7)
Maternal age, y 26.4 ±5.7 26.4 ±5.9 26.3 ±5.7 26.8 ±6.3 .94
Metro indexa
 Large metro 188 (41.1) 1238 (52.3) 195 (56.4) 41 (46.1) <.01
 Small metro 169 (37.0) 714 (30.2) 95 (27.5) 30 (33.7)
 Nonmetro 100 (21.9) 415 (17.5) 56 (16.2) 18 (20.2)
AIDS conditions 21 (4.6) 120 (5.1) 9 (2.6) 5 (5.6) .24
Comorbidity 199 (43.5) 886 (37.4) 110 (31.8) 36 (40.5) <.01
Cesarean delivery 245 (53.6) 1349 (57.0) 184 (53.2) 46 (51.7) .28
Mos enrolled in Medicaidb 21.2 ±10.7 22.9 ±10.8 8.6 ±9.9 15.1 ±12.5 <.01
Enrolled in Medicaid < 3 mob 18 (3.9) 74 (3.1) 151 (43.6) 17 (19.1) <.01
Treatment
 HAARTc 228 (49.9) 888 (37.5) 51 (14.7) 23 (25.8) <.01
 Suboptimal treatmentd 95 (20.8) 701 (29.6) 41 (11.9) 18 (20.2)
 No ARV 134 (29.3) 778 (32.9) 254 (73.4) 48 (53.9)

Note. ARV = antiretroviral therapy; HAART = highly active antiretroviral therapy.

a

Large metro = metropolitan area with 1 million residents or more; small metro = metropolitan area with fewer than 1 million residents; nonmetro = rural area.

b

Eligible months over 3 years of Medicaid claim data.

c

HAART included at least 1 nucleoside reverse-transcriptase inhibitor and at least 2 other agents.

d

Suboptimal treatment = some or any ARV treatment prescription other than HAART.